Brain Pericytes in Neurodegeneration

Brain Pericytes in Neurodegeneration

Overview

Brain pericytes are specialized perivascular cells that wrap around the endothelial cells of cerebral microvasculature, playing a critical structural and functional role in maintaining the blood-brain barrier (BBB) and cerebral homeostasis. These cells, accounting for approximately 5-10% of all vascular cells in the brain, have emerged as key players in neurodegenerative disease pathology. Pericytes are characterized by their position within the basement membrane surrounding brain capillaries and their intimate contact with endothelial cells through gap junctions and adhesion molecules. Increasing evidence demonstrates that pericyte dysfunction contributes to BBB breakdown, neuroinflammation, and neuronal loss across multiple neurodegenerative conditions including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS).

Function/Biology

Brain Pericytes in Neurodegeneration

Overview

Brain pericytes are specialized perivascular cells that wrap around the endothelial cells of cerebral microvasculature, playing a critical structural and functional role in maintaining the blood-brain barrier (BBB) and cerebral homeostasis. These cells, accounting for approximately 5-10% of all vascular cells in the brain, have emerged as key players in neurodegenerative disease pathology. Pericytes are characterized by their position within the basement membrane surrounding brain capillaries and their intimate contact with endothelial cells through gap junctions and adhesion molecules. Increasing evidence demonstrates that pericyte dysfunction contributes to BBB breakdown, neuroinflammation, and neuronal loss across multiple neurodegenerative conditions including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS).

Function/Biology

Pericytes represent a heterogeneous population of perivascular mesenchymal cells with multiple physiological functions. These cells express marker proteins including NG2 (chondroitin sulfate proteoglycan 4), PDGF receptor-beta (PDGFRβ), desmin, and vimentin. The primary structural role of pericytes involves stabilizing the microvasculature through physical contact with endothelial cells and production of extracellular matrix components. This interaction is mediated by several key adhesion molecules, including N-cadherin, VE-cadherin interaction through trans-endothelial peg-socket connections, and integrin-based focal adhesions. Beyond structural support, pericytes actively contribute to BBB maintenance by regulating endothelial tight junction proteins such as claudins, occludin, and zonula occludens-1 (ZO-1). Pericytes also produce vasoactive substances that regulate cerebral blood flow, including angiotensin II, endothelin-1, and nitric oxide. Additionally, these cells possess immunomodulatory properties, expressing major histocompatibility complex (MHC) molecules and producing cytokines that influence local immune responses.

Role in Neurodegeneration

Pericyte loss and dysfunction represent emerging hallmarks of neurodegeneration. In Alzheimer's disease, substantial pericyte degeneration correlates with amyloid-beta (Aβ) accumulation, particularly along cerebral amyloid angiopathy pathways. This pericyte decline precedes significant neuronal loss and BBB disruption in disease models, suggesting pericytes as early biomarkers and therapeutic targets. Similarly, in Parkinson's disease, evidence indicates progressive pericyte dysfunction associated with alpha-synuclein pathology and neuroinflammation. Pericyte damage compromises BBB integrity, allowing peripheral immune cell infiltration and exacerbating neuroinflammatory cascades. In ALS, pericyte dysfunction contributes to motor neuron degeneration through BBB disruption and impaired cerebrospinal fluid dynamics. The primary consequence of pericyte loss is increased BBB permeability, leading to pathological infiltration of peripherally-derived immune cells, leukocyte extravasation, and accumulation of neurotoxic plasma proteins in the parenchyma.

Molecular Mechanisms

Several molecular pathways link pericyte dysfunction to neurodegeneration. Aβ oligomers directly damage pericytes through receptor-mediated endocytosis involving low-density lipoprotein receptor-related protein 1 (LRP1), triggering pericyte apoptosis. Abnormal Wnt/β-catenin signaling impairs pericyte-endothelial crosstalk essential for BBB maintenance. The PDGFRβ-PDGF signaling axis, crucial for pericyte recruitment and survival, is dysregulated in neurodegenerative diseases. Hypoxia-inducible factor 1-alpha (HIF-1α) activation in dysfunctional pericytes perpetuates neuroinflammation through increased vascular endothelial growth factor (VEGF) production and enhanced macrophage infiltration. Oxidative stress and mitochondrial dysfunction impair pericyte energy metabolism and stress response pathways. Additionally, transforming growth factor-beta (TGF-β) dysregulation affects pericyte differentiation and function, while elevated phosphorylated tau may directly compromise pericyte integrity through microtubular disruption.

Clinical/Research Significance

Understanding pericyte pathology has substantial implications for neurodegeneration therapeutics. Pericyte stabilization through PDGFRβ activation shows promise in preclinical models. Angiopoietin-1 (Ang-1) administration enhances pericyte recruitment and BBB integrity. Pericyte-derived exosomes represent potential biomarkers for early neurodegeneration detection. Therapeutic strategies targeting pericyte survival, including mitochondrial support and oxidative stress reduction, are under investigation. Brain imaging techniques sensitive to pericyte dysfunction could enable early disease detection and treatment monitoring.

Related Entities

• Blood-Brain Barrier (BBB)
• Endothelial Cells
• Neuroinflammation
• Alzheimer's Disease
• Parkinson's Disease